NLRP3 and early-onset autosomal dominant Alzheimer disease: NLRP3 inflammasome has been reported to be associated with a variety of diseases, such as sepsis, gout, Alzheimer’s disease, atherosclerosis, diabetes and the new COVID-19 [50–54].